Chongqing Carelife Pharmaceutical Co., Ltd.

Established in 2000, Chongqing Carelife Pharmaceutical Co., Ltd. (Carelife) is a high-tech enterprise integrating R&D, production and sales of APIs. Carelife owns two state-of-the-art facilities for APIs manufacturing, complying with international and China cGMP. We have established a rigid quality assurance system, which reaches international advanced level. At present, API products have been respectively inspected and/or approved by US FDA, EDQM, Japan PMDA, German health authorities, Australia TGA, Canada TPD, India Ministry of Health, and China NMPA With its excellent product quality, Carelife is devoted to the development of the global markets with long term efforts, and We have established long-term and stable cooperation with several of the world's most distinguished biopharmaceutical corporations, including globally recognized Top 10 innovators and leading generic companies. Our products are exported to more than 40 countries and regions, including North America, Europe, Japan, Australia, Southeast Asia, and Latin America, etc. Looking into the future, all the staff of Carelife will keep the principle of regular management, quality first, production safety and environment protection, to develop the international and domestic markets, to create a win-win situation, with positive and steady steps. Carelife, your trustworthy partner!